ACM
Aisling Capital Management Portfolio holdings
AUM
$456M
1-Year Est. Return
131.57%
1 Year Est. Return
+131.57%
AUM
$456M
AUM Growth
+$96.8M
(+27%)
Holding
15
Top Buys
| 1 | +$6.54M | |
| 2 | +$2.87M | |
| 3 | +$1.55M | |
| 4 |
BridgeBio Pharma
BBIO
|
+$1.12M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
BridgeBio Pharma
BBIO
$13.8B
| $316M | 69.29% |
6,089,611
+21,486
|
|
||
|
VRNA
2
DELISTED
Verona Pharma
VRNA
| $65.7M | 14.39% |
615,352
|
|
||
3
Syndax Pharmaceuticals
SNDX
$1.66B
| $20.3M | 4.44% |
1,316,806
|
|
||
4
Nuvation Bio
NUVB
$2.7B
| $11M | 2.4% |
2,960,659
+419,650
|
|
||
5
Monte Rosa Therapeutics
GLUE
$1.03B
| $10.9M | 2.39% |
1,472,331
|
|
||
|
BCAX
6
Bicara Therapeutics
BCAX
$949M
| $8.98M | 1.97% |
568,919
|
|
||
|
CMPS
7
Compass Pathways
CMPS
$503M
| $6.87M | 1.5% |
1,198,418
|
|
||
|
BBOT
8
BridgeBio Oncology
BBOT
$977M
| $6.54M | 1.43% |
+564,625
|
|
||
9
Biomea Fusion
BMEA
$71.4M
| $4.14M | 0.91% |
2,048,757
|
|
||
10
Scholar Rock
SRRK
$4.28B
| $2.87M | 0.63% |
+77,031
|
|
||
11
CalciMedica
CALC
$61.8M
| $1.6M | 0.35% |
521,114
|
|
||
12
Aclaris Therapeutics
ACRS
$283M
| $825K | 0.18% |
434,455
|
|
||
13
Marker Therapeutics
MRKR
$19.7M
| $290K | 0.06% |
325,370
|
|
||
|
OKUR
14
OnKure Therapeutics
OKUR
$38.5M
| $244K | 0.05% |
88,607
|
|
||
|
ELEV
15
DELISTED
Elevation Oncology
ELEV
| – | – |
-2,834,910
|
|